Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Targeted oncology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Zhang%2C+Lele%22&type=Person&filter%5B%5D=journalStr%3A%22Targeted+oncology%22
/vufind/Search/Results?lookfor=%22Zhang%2C+Lele%22&type=Person&filter%5B%5D=journalStr%3A%22Targeted+oncology%22
Search /vufind/Search2/Results?lookfor=%22Zhang%2C+Lele%22&type=Person&filter%5B%5D=journalStr%3A%22Targeted+oncology%22
PubPharm (12)
1
Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation : A Long-Term Survival Analysis
enthalten in:
Targeted oncology
| 2020
von
Chen, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
2
Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis
enthalten in:
Targeted oncology
| 2020
von
Chen, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
3
Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis
enthalten in:
Targeted oncology
| 2020
von
Chen, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
4
Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis
enthalten in:
Targeted oncology
| 2020
von
Chen, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
5
Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements : Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib
enthalten in:
Targeted oncology
| 2019
von
Zhao, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
6
Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib
enthalten in:
Targeted oncology
| 2019
von
Zhao, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
7
Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib
enthalten in:
Targeted oncology
| 2019
von
Zhao, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
8
Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib
enthalten in:
Targeted oncology
| 2019
von
Zhao, Y.
|
Wang, S.
|
Zhang, B.
| +5
Wird geladen...
9
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients : a Retrospective Study and Literature Review
enthalten in:
Targeted oncology
| 2018
von
Zhang, B.
|
Zhang, Y.
|
Xu, J.
| +8
Wird geladen...
10
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review
enthalten in:
Targeted oncology
| 2018
von
Zhang, B.
|
Zhang, Y.
|
Xu, J.
| +8
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Targeted oncology
Medienart
12
Aufsätze
9
E-Artikel
9
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
Targeted oncology
Thema
3
EC 2.7.10.1
3
Journal Article
2
53AH36668S
2
Anaplastic Lymphoma Kinase
2
Crizotinib
2
ErbB Receptors
1
3C06JJ0Z2O
1
9G6U5L461Q
1
ALK protein, human
1
Acrylamides
1
Aniline Compounds
1
Biomarkers, Tumor
1
Crown Ethers
1
DA87705X9K
1
EGFR protein, human
1
Erlotinib Hydrochloride
1
Gefitinib
1
Quinazolines
1
Research Support, Non-U.S. Gov't
1
Review
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2020-
8
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...